| Year |
Citation |
Score |
| 2022 |
Miller EK, Goldberg AM, Janoff EN, Brown ST, Curtis JL, Bonomo RA, Shih MC, Gleason TC. Designing and implementing methodology for double-blind, placebo-controlled clinical trials using blood products within the Department of Veterans Affairs. Clinical Trials (London, England). 17407745211069703. PMID 35229691 DOI: 10.1177/17407745211069703 |
0.36 |
|
| 2021 |
Krystal JH, Chow B, Vessicchio J, Henrie AM, Neylan TC, Krystal AD, Marx BP, Xu K, Jindal RD, Davis LL, Schnurr PP, Stein MB, Thase ME, Ventura B, Huang GD, ... Shih MC, et al. Design of the national adaptive trial for PTSD-related insomnia (NAP study), VA cooperative study program (CSP) #2016. Contemporary Clinical Trials. 106540. PMID 34416369 DOI: 10.1016/j.cct.2021.106540 |
0.354 |
|
| 2019 |
Xenogiannis I, Rangan B, Uyeda L, Banerjee S, Edson R, Bhatt D, Holmes D, Rao S, Mavromatis K, Ramanathan K, McFalls E, Garcia S, Uretsky B, Latif F, Armstrong E, ... ... Shih M, et al. TCT-674 In-Stent Restenosis in Saphenous Vein Grafts: Insights From the DIVA trial Journal of the American College of Cardiology. 74: B661. DOI: 10.1016/J.Jacc.2019.08.799 |
0.326 |
|
| 2015 |
Shih MC, Turakhia M, Lai TL. Innovative designs of point-of-care comparative effectiveness trials. Contemporary Clinical Trials. PMID 26099528 DOI: 10.1016/J.Cct.2015.06.014 |
0.617 |
|
| 2014 |
Shih M, Lavori PW. Sequential Methods For Comparative Effectiveness Experiments: Point Of Care Clinical Trials Statistica Sinica. DOI: 10.5705/Ss.2012.231S |
0.433 |
|
| 2012 |
Lai TL, Lavori PW, Shih MC. Sequential design of phase II-III cancer trials. Statistics in Medicine. 31: 1944-60. PMID 22422502 DOI: 10.1002/Sim.5346 |
0.616 |
|
| 2012 |
Lai TL, Lavori PW, Shih MC, Sikic BI. Clinical trial designs for testing biomarker-based personalized therapies. Clinical Trials (London, England). 9: 141-54. PMID 22397801 DOI: 10.1177/1740774512437252 |
0.604 |
|
| 2012 |
Lai TL, Lavori PW, Shih MC. Adaptive trial designs. Annual Review of Pharmacology and Toxicology. 52: 101-10. PMID 21838549 DOI: 10.1146/Annurev-Pharmtox-010611-134504 |
0.61 |
|
| 2010 |
Matchar DB, Jacobson A, Dolor R, Edson R, Uyeda L, Phibbs CS, Vertrees JE, Shih MC, Holodniy M, Lavori P. Effect of home testing of international normalized ratio on clinical events. The New England Journal of Medicine. 363: 1608-20. PMID 20961244 DOI: 10.1056/Nejmoa1002617 |
0.327 |
|
| 2010 |
Shih MC, Lai TL, Heyse JF, Chen J. Sequential generalized likelihood ratio tests for vaccine safety evaluation. Statistics in Medicine. 29: 2698-708. PMID 20799244 DOI: 10.1002/Sim.4036 |
0.581 |
|
| 2009 |
Lai TL, Shih M, Su Z. Tests and confidence intervals for secondary endpoints in sequential clinical trials Biometrika. 96: 903-915. DOI: 10.1093/Biomet/Asp063 |
0.644 |
|
| 2008 |
Goldman S, McCarren M, Morkin E, Ladenson P, Edson R, Warren S, Ohm J, Thai H, Churby L, Barnhill J, O'Brien T, Anand I, Warner A, Dunlap M, Hattle B, ... ... Shih M, et al. DITPA, a Thyroid Hormone Analog to Treat Heart Failure: Phase II Trial VA Cooperative Study Journal of Cardiac Failure. 14: 796. DOI: 10.1016/J.Cardfail.2008.10.008 |
0.318 |
|
| 2006 |
Lai TL, Shih MC, Wong SP. A new approach to modeling covariate effects and individualization in population pharmacokinetics-pharmacodynamics. Journal of Pharmacokinetics and Pharmacodynamics. 33: 49-74. PMID 16402288 DOI: 10.1007/s10928-005-9000-2 |
0.491 |
|
| 2006 |
Lai TL, Shih MC, Zhu G. Modified Haybittle-Peto group sequential designs for testing superiority and non-inferiority hypotheses in clinical trials. Statistics in Medicine. 25: 1149-67. PMID 16189814 DOI: 10.1002/Sim.2357 |
0.579 |
|
| 2004 |
Lai TL, Shih M. Power, sample size and adaptation considerations in the design of group sequential clinical trials Biometrika. 91: 507-528. DOI: 10.1093/biomet/91.3.507 |
0.578 |
|
| Show low-probability matches. |